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Abstract
Background: Cardiovascular disease (CVD) is the leading cause of death worldwide. Cardiac rehabilitation (CR) is
aimed at improving health behaviors to slow or reverse the progression of CVD disease. Exercise is a central
element of CR. Technologies such as mobile phones and the Internet (mHealth) offer potential to overcome many
of the psychological, physical, and geographical barriers that have been associated with lack of participation in
exercise-based CR. We aim to trial the effectiveness of a mobile phone delivered exercise-based CR program to
increase exercise capacity and functional outcomes compared with usual CR care in adults with CVD. This paper
outlines the rationale and methods of the trial.
Methods: A single-blinded parallel two-arm randomized controlled trial is being conducted. A total of 170 people
will be randomized at 1:1 ratio either to receive a mHealth CR program or usual care. Participants are identified by
CR nurses from two metropolitan hospitals in Auckland, New Zealand through outpatient clinics and existing
databases. Consenting participants are contacted to attend a baseline assessment. The intervention consists of a
theory-based, personalized, automated package of text and video message components via participants’ mobile
phones and the Internet to increase exercise behavior, delivered over six months. The control group will continue
with usual CR. Data collection occurs at baseline and 24 weeks (post-intervention). The primary outcome is change
in maximal oxygen uptake from baseline to 24 weeks. Secondary outcomes include post-intervention measures on
self-reported physical activity (IPAQ), cardiovascular risk factors (systolic blood pressure, weight, and waist to hip
ratio), health related quality of life (SF-36), and cost-effectiveness.
Discussion: This manuscript presents the protocol for a randomized controlled trial of a mHealth exercise-based
CR program. Results of this trial will provide much needed information about physical and psychological well-
being, and cost-effectiveness of an automated telecommunication intervention. If effective, this intervention has
enormous potential to improve the delivery of CR and could easily be scaled up to be delivered nationally (and
internationally) in a very short time, enhancing the translational aspect of this research. It also has potential to
extend to comprehensive CR (nutrition advice, smoking cessation, medication adherence).
Trial RegistrationACTRN12611000117910
Background
An estimated 16.7 million or 29% of total global deaths
result from the various forms of cardiovascular disease
(CVD). The majority of deaths were either due to
ischemic heart disease or stroke [1]. By 2020 the global
burden of fatal and non-fatal CVD is anticipated
to grow in importance in both absolute and relative
terms [1]. Approximately 68 million deaths occur world-
wide of all causes, of which approximately 25 million
(37%) deaths will be due to cardiovascular causes, with
ischemic heart disease accounting for about 11 million
deaths [1]. The total number of disability affected life
years (DALYs) attributable to CVD is expected to rise
from 134 million in 1990 to about 204 million in 2020.
Ischemic heart disease is expected to be the leading
cause of DALYs in 2020 (82 million DALYs) [1].
Cardiac rehabilitation (CR) is an essential component
of secondary prevention of CVD, and is a complex
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including risk factor education, psychological therapy,
and medication [2]. International guidelines consistently
identify exercise therapy as a central element of CR
[3-6]. Exercise-based CR have been shown to be cost-
effective for those who participate [7].
A Cochrane systematic review of exercise-based CR
reported that all-cause mortality was reduced by 27%
(OR 0.73, 95% CI 0.54 to 0.98) with exercise-only reha-
bilitation compared with usual care [2]. The reduction
in CVD mortality was 31% (random effects model OR
0.69, 95% CI 0.51 to 0.94) with exercise-only rehabilita-
tion [2]. These findings have been supported by a sepa-
rate meta-analysis [8].
There are numerous benefits associated with exercise
training in patients with CVD, including improvement
in exercise tolerance as assessed by both exercise dura-
tion and oxygen uptake (VO2), peak cardiac output,
peak cardiac power output, and overall cardiac reserve
[9-12]. Exercise is also associated with a constellation of
changes such as improvements in lipid profile [2], insu-
lin sensitivity, reduction in BMI, percentage body fat,
r e d u c t i o ni ni n f l a m m a t o r yv ariables, and improvement
in autonomic tone [12].
Despite the documented benefits of CR, provision is
inadequate in all countries in which it has been mea-
sured [13]. In New Zealand, uptake of CR is only 20%
with high levels of dropout after enrolment [14]. Inter-
national data show that adherence with exercise recom-
mendations is low [15-17]; between 10% and 36% of
individuals dropout of supervised exercise programs.
Long-term exercise adherence is worse, with up to 50%
of people not participating in regular exercise at 6 [18]
and 18-months [16]. Those who do not adhere to exer-
cise-based CR do not realize the benefits of regular
exercise such as increased cardiovascular fitness,
decreased weight, and improved lipid profile [15].
The main reasons that people give for not accepting
the invitation to attend center based CR classes, which
include supervised exercise–held for groups in hospitals,
gymnasiums, or community centers–are problems with
access and parking [3,19,20], a dislike of these groups
[21], and work or domestic commitments [22-24]. Psy-
chological barriers that have been associated with lack
of participation in CR programs include the perceived
benefits of rehabilitation [25,26], lack of self-motivation
and self-esteem [3,17,27], and lack of social support
[28]. New Zealand research has reported similar findings
with lack of access to transport associated with poor
attendance at CR [14].
Many of these problems can be overcome by home-
based rehabilitation, which has been introduced in an
attempt to widen access and participation [29]. A recent
Cochrane review and meta-analysis [30] of 12 studies
(n = 1938) found no differences between home-based
and center-based CR in terms of mortality (relative risk
1.31, 95%CI 0.65 to 2.66), cardiac events, exercise capacity
(standardized mean difference -0.11, -0.35 to 0.13), modifi-
able risk factors (weighted mean difference systolic blood
p r e s s u r e( 0 . 5 8m mH g ,- 3 . 2 9m mH gt o4 . 4 4m mH g ) ,
total cholesterol (-0.13 mmol/l, -0.31 mmol/l to
0.05 mmol/l), low density lipoprotein cholesterol
(-0.15 mmol/l, -0.31 mmol/l to 0.01 mmol/l), or health
related quality of life. In the home-based participants,
there was evidence of superior adherence; however health-
care costs of the two forms of CR were similar. While
these findings are encouraging and support the use of
home-based cardiac rehabilitation, data from the United
Kingdom suggest that only about 20% of CR programs
currently offer an evidence-based home option [30].
In terms of increasing physical activity, telephone-
based interventions can be effective [31,32]; however
mobile phones promise an even more effective way to
reach many people who seldom access CR services.
Mobile phones are carried by most adults most of the
time. Mobile health or mHealth programs, which include
mobile phones and the Internet, can be delivered any-
where at any time, removing geographical barriers to CR.
Communication with participants can be regular and fre-
quent, and messages can be delivered in a time-sensitive
or time-appropriate way to support behavior change in a
more continuous manner. Programs delivered by mobile
phone do not require participants to attend a clinic and
c o u l db eu s e da sa na l t e r n a t i ve option for people that
find it difficult to attend exercise sessions. This makes
programs far more proactive (initiated by the service)
rather than requiring action by the participant before
they can start to impart information or provide support.
Although automated, the electronic nature of the pro-
gram means it can be tailored to specific cultural or age
groups, and health needs.
This paper presents the rationale and methods of a
randomized controlled trial to investigate the effects of
an mHealth delivered exercise-based CR program to
improve exercise capacity and functional outcomes in
people with CVD.
Method/Design
The study design is a single-blinded two-arm parallel
randomized controlled trial comparing an mHealth
exercise-based program of CR to usual CR alone.
Aims
The primary aim is to investigate the effects of an
mHealth delivered exercise-based CR program to
increase exercise capacity compared with usual care
(exercise advice and an offer to participate in a cardiac
club) in New Zealand adults with a diagnosis of CVD.
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vention on physical activity, systolic blood pressure,
weight, waist to hip ratio, health related quality of life,
and cost effectiveness.
Study sample
Eligible participants are adults aged 18 years or more
with a clinically documented diagnosis of ischemic heart
disease (angina, myocardial infarction, revascularization,
including angioplasty, stent or coronary artery bypass
graft) within the previous three to twelve months. Parti-
cipants must be current outpatients who are clinically
stable, able to perform exercise, can understand and
write English, own a mobile phone, and have access to
the Internet. Participants who have been admitted to
hospital with heart disease within the previous six
weeks, have terminal cancer, or have significant exercise
limitations other than CVD are excluded.
Eligible participants are identified by research nurses
from two metropolitan hospitals through outpatient
clinics and existing databases. Research nurses contact
potential participants to determine their interest in the
trial. Those agreeing to participate are screened for elig-
ibility and sent a study pack, which includes a partici-
pant information sheet and consent form. Contact
details of interested participants are sent to the research
team. After one week, participants are telephoned to
confirm their interest in the study and schedule a base-
line assessment.
Sample size calculation
T h et a r g e ts a m p l es i z eo f1 7 0p a r t i c i p a n t s( 8 5p e r
group) will provide 90% power at 5% level of signifi-
cance (two-sided) to detect a treatment difference of at
least 2.5 ml
-1.kg.min
-1 between the two groups, on
change in VO2max from baseline to 24 weeks assuming a
standard deviation of 5 ml
-1.kg.min
-1. Recruiting at least
50 Māori (indigenous) participants (25 per arm) will
provide 80% power to detect a treatment difference of
4.0 ml.kg
-1.min
-1 between the two groups under the
same assumptions.
Ethics approval
Ethical approval for the trial was received from the
Northern X Regional Ethics Committee (NTX/10/10/
099). Approval was also obtained from the two Metro-
politan Hospitals’ respective Ethics Approval
Committees.
Randomization and blinding
Participants are randomly allocated to either the control
(usual care) or intervention (mHealth) arms at a 1:1
ratio using a computerized stratified (sex, ethnicity, and
adherence to Phase 2 CR) minimization [33] sequence.
Ethnicity is based on self-identification as Māori or non-
Māori. Adherence to CR is classified as attending at
least one community CR session.
The allocation sequence is overseen by the project sta-
tistician (YJ). Assessors of the primary outcomes will be
blinded to treatment allocation; however it is not possi-
ble to blind participants to their allocation.
Intervention
The intervention is a personalized automated program
of SMS (short messaging service) text messages deliv-
ered over six months via mobile phone and supported
with a personalized website that participants can log on
to. This includes personalized feedback on progress
against goals, as well as information on various forms of
exercise, and links to other websites (e.g. local exercise
programs and cardiac clubs), as well as CR related
information.
The goal of the program is to have individuals partici-
pate in moderate to vigorous aerobic-based exercise for
a minimum of 30 minutes (preferably more) on most days
(at least 5) of the week, in line with current recommenda-
tions [34], and American College of Sports Medicine
(ACSM) guidelines [35]. Consistent with recommenda-
tions for supervised home-based exercise [36] the program
involves regular exercise prescription, technical support,
and provision of behavioral strategies (goal setting, exercise
scheduling and overcoming barriers) to increase exercise
adherence, delivered via mobile phone. The intervention
also focuses on altering the key mediators of behavior
change, including self-efficacy, social support, intention
and motivation. Specific details are provided below.
Exercise prescription
A core component of the program involves a prescribed
regimen of individualized exercise based on personal pre-
ferences and participant’s current levels of fitness. A base-
line exercise test forms the basis for subsequent exercise
prescription. ACSM guidelines for exercise in cardiac
patients are followed [35]. The prescribed exercise inten-
sity is sufficient to induce a “training effect”, yet below a
metabolic load that evokes abnormal clinical signs or
symptoms. Exercise duration is increased according to
symptoms and clinical status. Exercise intensity is
increased gradually as tolerated [15]. Criteria for progres-
sion is according to the following order: duration, fre-
quency, then intensity [10]. Participants are taught and
encouraged to use ratings of perceived exertion (RPE) to
achieve the desired intensity. An equivalent RPE level of
11 to 13 (6-20 scale) ("fairly light” and “somewhat hard”)
[37] is used during the early stages and 13 to 15 ("some-
what hard” to “hard”) in the latter stages [10].
A recent systematic review concluded that interventions
at the level of the individual incorporating components of
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munications can encourage people to walk more [15].
Hence these components are included in this intervention.
Walking is the primary (default) mode of activity but
other activities such as swimming and cycling are encour-
aged based on individual preferences, past history, and
access to existing resources (e.g., swimming pool, gym). A
pedometer is provided to participants in the intervention
g r o u pa n ds t e pc o u n t sa r eu s e dt oi n d i c a t ev o l u m eo f
activity for each given week. SMS messages are sent to
participants outlining their prescribed exercise for each
week, including duration, frequency, and intensity of exer-
cise. Contact is more intensive during the exercise initia-
tion period (12-weeks).
Support and behavior change strategies
Participants also receive SMS messages focused on altering
key mediators of physical activity to facilitate adherence to
exercise behavior. Messages include strategies on over-
coming barriers to be active, increasing motivation to
exercise, scheduling exercise into one’s daily routine, and
goal setting. The behavioral support program is grounded
in self-efficacy theory [20,38-40], which is a key psychoso-
cial determinant of adherence to exercise and physical
activity [18,41,42].
Internet support
A website is also available for participants to access,
which allows participants to retrieve on demand any of
the messages sent to their phones. Video messages,
motivational messages, and weekly health and exercise
tips are also included. Using the website, participants
can document and monitor their physical activity pro-
gress, set goals, identify barriers to exercise and generate
solutions to overcome these. Participants can also view
role model videos and access other CR information. For
example, regular postings are added to the website
encouraging participants to access existing community-
based programs, for those interested.
An important component of the intervention is the
use of role modeling, which refers to the process of
learning behaviors from viewing other people’s behaviors
and the outcomes of that behavior [39,40]. Role model-
ing is an important source of self-efficacy and is one of
the primary modes used by individuals to gain socializa-
tion information and cognitive skills [39,40].
During the intervention, participants can access brief
(30 - 120 sec) videoed vignettes of other cardiac patients
discussing their experiences of exercise, the types of
problems they faced, how they coped, and any advice
they can offer. Consistent with theory and to enhance
the motivational properties of the videos, a variety of
different models are used to cover general age, gender,
and ethnic groups. Other vignettes from cardiologists,
cardiac rehabilitation nurse specialists, and exercise
physiologists are included, which provide information
outlining the benefits of exercise, physiological responses
and safety issues.
Control group
The control group is directed to receive usual commu-
nity-based CR, which currently involves encouragement
to be physically active and an offer to join a local cardiac
club.
Study outcome measures
Assessments are undertaken in a physiology laboratory
at the University of Auckland at baseline and 24 weeks
post-randomization. The research team arranges an
appointment at an agreed time to undergo assessment.
To facilitate attendance at the assessments participants
are offered taxi transport to and from testing, or are
provided with a petrol voucher to off-set any travel
costs. On arrival, the researcher explains procedures and
collects the signed consent forms. Physical measure-
ments (blood pressure, height, weight, waist and hip
circumference are conducted prior to a maximal oxygen
uptake treadmill test (VO2max) to assess exercise capa-
city. Following a rest, participants complete a question-
naire booklet and a six minute walk test.
Primary outcome
The primary outcome is exercise capacity measured via
maximal oxygen uptake (VO2max) at 24-weeks. A stan-
dardized exercise testing treadmill protocol is used to
assess VO2max using gas analysis. A ramp protocol is
initiated at a comfortable walking speed, with a gradient
increase of 2 degree steps at each minute. Exercise test-
ing follows ACSM guidelines [9] and is conducted by a
trained physiologist. A medical physician is available to
deal with any emergencies that might arise.
Secondary outcomes
Weight, waist and hip circumference, and blood pres-
sure are measured using standard procedures. The Pul-
secor R6.5 suprasystolic measurement system/BPPlus is
used to assess systolic and diastolic pressure as well as
arterial compliance. Participant’s height is measured to
the nearest 0.1 cm using a stadiometer and weight to
the nearest 0.1 kilograms using electronic scales. Body
mass index is derived from the weight divided by height
(m) squared. Waist circumference is measured using a
flexible tape measure placed around the participant’s
waist at the level of the umbilicus. Hip circumference is
measured using an anthropometric measuring tape
placed around the furthest protrusion of the buttocks as
seen from a lateral perspective. Waist-hip ratio calcu-
lated according to ISAK protocols [43].
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self-confidence) to exercise and motivations are
assessed. Task self-efficacy is assessed using a scale
adapted from the Self-Efficacy Scale [44]. Participants
rate their confidence to perform physical activities for
increasing periods of time (i.e., 10, 30, and 60 min) at
three intensities (i.e., easy, moderate, and hard). A key is
provided to define the various intensity levels. Mean
scores are calculated with higher values indicating
greater efficacy to perform physical activity for longer
duration and greater intensity.
Participants’ confidence to exercise in the face of obsta-
cles (barrier efficacy) is assessed using the Barriers Effi-
cacy Scale [44]. Participants rate their confidence to
overcome seven common reasons preventing people
from participating in exercise sessions on a scale ranging
from 0% (no confidence at all) to 100% (completely confi-
dent). Mean scores are calculated with higher values indi-
cating greater efficacy to overcome barriers to exercise.
Participants’ confidence to schedule exercise into their
daily lives is assessed with three items [45]. Participants
rate their confidence on a scale ranging from 0% (no con-
fidence at all) to 100% (completely confident). Mean
scores are calculated with higher values indicating greater
efficacy to schedule exercise regularly into their daily lives.
Self-determination to exercise is operationalized using
the Locus of Causality for Exercise Scale; a reliable and
valid three-item self-report measure of the extent to
which participants feel they choose to exercise with no
sense of coercion [46].
Participants rate how much they agree or disagree
with each statement on a seven-item Likert scale from 1
(Strongly disagree) to 7 (Strongly agree) indicating their
motivation to perform exercise. Mean scores are calcu-
lated and higher scores indicate greater self-determina-
tion or a more internal perceived locus of causality.
Physical activity is assessed using the International Phy-
sical Activity Questionnaire, a reliable and validated 7-day
recall measure which provides a comprehensive evaluation
of daily physical activities, and assesses the time spent
walking, and engaging in light, moderate, and vigorous-
intensity activities across various domains [47].
Health related quality of life is assessed using the stan-
dard version of the Short Form SF36 version 2 [22]. The
SF36v.2 measures perceived health across eight domains
using a 0-100 scale: 1) Physical Functioning; (2) Role-
Physical; (3) Bodily Pain; (4) General Health; (5) Vitality;
(6) Social Functioning; (7) Role-Emotional; and (8) Mental
Health. The items and scales are scored so that a higher
score indicates a better health state. Two summary mea-
sures, physical (PCS) and mental (MCS) components, can
also be calculated using the transformed 0-100 scales.
Participants complete the 6-min walk test–ar e l i a b l e
and valid measure of functional outcome [20], which is
used by many cardiac rehabilitation programs both for
initial assessment and to document functional outcomes
after completion of the cardiac rehabilitation program
[7]. It is simple to conduct, has excellent patient accep-
tance because exercise levels during the test closely
resemble usual patient activities, and costs of adminis-
tration are low.
Cost information, including cost of program, and
direct medical costs (including cost of treatment, pri-
mary care, secondary care and over-the-counter medica-
tions) are collected for the cost-effective analysis. The
EQ5D [48] is used to obtain a single preference index
for calculation of Quality Adjusted Life Year (QALY) to
assess cost per QALY for comparison with other CR
programs. EQ-5D is a descriptive system of health-
related quality of life states consisting of five dimensions
(mobility, self-care, usual activities, pain/discomfort,
anxiety/depression) each of which can take one of three
responses. The responses record three levels of severity
(no problems/some or moderate problems/extreme pro-
blems) within a particular EQ-5D dimension.
Adverse events (AE) including any illness, sign, symp-
tom, or clinically significant abnormality that has
appeared or worsened during the course of the clinical
trial, regardless of causal relationship to the treatment(s)
under study, are also recorded.
Statistical analyses
Statistical analyses will be performed using SAS version
9.2 (SAS Institute Inc. Cary NC) and R version 2.12 (R
Foundations for Statistical Computing), with a 5% signifi-
cance level (two-sided) maintained throughout the ana-
lyses. Treatment evaluations will be performed on the
principle of intention to treat (ITT), using the observed
data collected from all randomized participants. Missing
data in the primary outcome measure will be imputed
using a prespecified approach. The analysis of covariance
(ANCOVA) regression model will be used to evaluate the
main treatment effect on change in VO2max from baseline
to 24 weeks, adjusting for baseline values, age, sex, self-
identified ethnicity, and CR adherence (stratification fac-
tors). A similar approach will be used for other continuous
outcome measures. Logistic regression model will be con-
sidered for estimating the proportion of participants meet-
ing physical activity recommendations. A prespecified
analysis plan outlines the detailed statistical methods.
Discussion
The mHealth intervention trial described in this paper is
the first of its kind to investigate the effect on an objec-
tive outcome such as VO2max. Other mobile phone
interventions exist for cardiac patients; however our
proposed research differs considerably in the application
of technology. For example, the Australian e-health
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nology-based care assessment platform for CR, which is
currently being trialed [49]. The care assessment plat-
form includes video or teleconferencing with ‘mentors’,
whereas our program is completely automated and uti-
lizes SMS and the Internet to deliver specific theory
based behavior change strategies.
Results from this research have enormous potential to
improve the delivery of CR and could easily be scaled
up to be delivered nationally (and internationally) in a
very short time, enhancing the translational aspect of
this research. It has potential to extend to comprehen-
sive CR (nutrition advice, medication adherence). The
mHealth program could be offered to cardiac patients as
an adjunct to existing services and could also be
exported as a delivery model for future health care pro-
grams. This research has potential to improve access to
health care programs and could be used to inform
future policy and health care interventions.
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